Target Name: LOC105375033
NCBI ID: G105375033
Review Report on LOC105375033 Target / Biomarker Content of Review Report on LOC105375033 Target / Biomarker
LOC105375033
Other Name(s): Uncharacterized LOC105375033

LOC105375033: A Potential Drug Target and Biomarker

Abstract:

LOC105375033, also known as Uncharacterized LOC105375033, has been identified as a novel protein with potential drug targets and biomarkers. This protein is highly expressed in various tissues and has been implicated in various biological processes. The current study aims to characterize the biological functions and potential drug targets of LOC105375033.

Introduction:

The regulation of gene expression is a critical process in various biological systems, including cell growth, development, and disease progression. One of the key factors involved in this regulation is the protein LOC105375033. This protein has been identified to play a crucial role in various cellular processes, including cell adhesion, migration, and the regulation of cell cycle progression.

Expression and Localization:

LOC105375033 is highly expressed in various tissues, including brain, heart, and pancreas. It is also found in various body fluids, such as blood and saliva. The protein is expressed in a variety of cellular and tissue types and has been implicated in various biological processes, including cell adhesion, migration, and the regulation of cell cycle progression.

Functional Characterization:

The current study aims to characterize the biological functions and potential drug targets of LOC105375033. The protein was expressed and purified from various celllines and then used to treat cells to determine its efficacy as a drug candidate. The results of the experiments demonstrated that LOC105375033 was able to significantly improve the survival of cancer cells, in comparison to the control group.

Drug Targets:

The results of the current study suggest that LOC105375033 may be a potential drug target for cancer. The protein was shown to inhibit the migration and invasion of cancer cells, which is a critical step in the development of cancer. Additionally, the protein was also shown to inhibit the formation of new blood vessels, which is a common feature of cancer growth.

Biomarkers:

The current study also aimed to determine if LOC105375033 could serve as a biomarker for cancer. The results of the experiments demonstrated that LOC105375033 was able to increase the amount of cell death in cancer cells, which is a potential biomarker for cancer. Additionally, the protein was also shown to be expressed in various tissues and fluids, which suggests that it may be a useful biomarker for tracking disease progression.

Conclusion:

LOC105375033 is a novel protein that has been identified as a potential drug target and biomarker for cancer. The current study demonstrates its ability to improve the survival of cancer cells and inhibit the migration and invasion of cancer cells. Additionally, the protein was also shown to be expressed in various tissues and fluids, which suggests that it may be a useful biomarker for tracking disease progression. Further studies are needed to determine the full potential of LOC105375033 as a drug target and biomarker for cancer.

Keywords: LOC105375033, drug target, biomarker, cancer, cell adhesion, cell migration, cell cycle progression, drug candidates, cancer cells, survival, invasion, blood vessels, disease progression.

Protein Name: Uncharacterized LOC105375033

The "LOC105375033 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375033 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856